These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 24125425

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A functional variant of the dimethylarginine dimethylaminohydrolase-2 gene is associated with myocardial infarction in type 2 diabetic patients.
    Mannino GC, Pezzilli S, Averta C, Fuoco A, Spiga R, Mancuso E, Di Fatta C, Perticone F, Prudente S, Trischitta V, Andreozzi F, Sesti G.
    Cardiovasc Diabetol; 2019 Aug 13; 18(1):102. PubMed ID: 31409409
    [Abstract] [Full Text] [Related]

  • 3. A functional variant of the dimethylarginine dimethylaminohydrolase-2 gene is associated with insulin sensitivity.
    Andreozzi F, Presta I, Mannino GC, Scarpelli D, Di Silvestre S, Di Pietro N, Succurro E, Sciacqua A, Pandolfi A, Consoli A, Hribal ML, Perticone F, Sesti G.
    PLoS One; 2012 Aug 13; 7(4):e36224. PubMed ID: 22558392
    [Abstract] [Full Text] [Related]

  • 4. Chronic renal impairment and DDAH2-1151 A/C polymorphism determine ADMA levels in type 2 diabetic subjects.
    Marra M, Marchegiani F, Ceriello A, Sirolla C, Boemi M, Franceschi C, Spazzafumo L, Testa I, Bonfigli AR, Cucchi M, Testa R.
    Nephrol Dial Transplant; 2013 Apr 13; 28(4):964-71. PubMed ID: 23129820
    [Abstract] [Full Text] [Related]

  • 5. The Functional Polymorphism of DDAH2 rs9267551 Is an Independent Determinant of Arterial Stiffness.
    Averta C, Mancuso E, Spiga R, Miceli S, Succurro E, Fiorentino TV, Perticone M, Mannino GC, Thamtarana PJ, Sciacqua A, Sesti G, Andreozzi F.
    Front Cardiovasc Med; 2021 Apr 13; 8():811431. PubMed ID: 35047582
    [Abstract] [Full Text] [Related]

  • 6. Circulating methylarginine levels and the decline in renal function in patients with chronic kidney disease are modulated by DDAH1 polymorphisms.
    Caplin B, Nitsch D, Gill H, Hoefield R, Blackwell S, MacKenzie D, Cooper JA, Middleton RJ, Talmud PJ, Veitch P, Norman J, Wheeler DC, Leiper JM.
    Kidney Int; 2010 Mar 13; 77(5):459-67. PubMed ID: 20010544
    [Abstract] [Full Text] [Related]

  • 7. The role of adipose tissue asymmetric dimethylarginine/dimethylarginine dimethylaminohydrolase pathway in adipose tissue phenotype and metabolic abnormalities in subtotally nephrectomized rats.
    Minakuchi H, Wakino S, Hosoya K, Sueyasu K, Hasegawa K, Shinozuka K, Yoshifuji A, Futatsugi K, Komatsu M, Kanda T, Tokuyama H, Hayashi K, Itoh H.
    Nephrol Dial Transplant; 2016 Mar 13; 31(3):413-23. PubMed ID: 26516203
    [Abstract] [Full Text] [Related]

  • 8. Association between estimated glomerular filtration rate (eGFR) and asymmetric dimethylarginine (ADMA) concentrations among the elderly in a rural community: a cross-sectional study.
    Choi HR, Lee SW, Jeon DH, Hur NW, Youm Y, Kim HC.
    BMC Geriatr; 2019 Dec 23; 19(1):370. PubMed ID: 31870320
    [Abstract] [Full Text] [Related]

  • 9. [Significance of the factors of hypoxia and endothelial dysfunction in kidney injury in the presence of obesity].
    Galiamov MG, Saginova EA, Severova MM, Samokhodskaia LM, Krasnova TN, Sholomova VI, Sorokin IuD, Mukhin NA.
    Ter Arkh; 2013 Dec 23; 85(6):31-7. PubMed ID: 23866596
    [Abstract] [Full Text] [Related]

  • 10. Ex vivo gene transferring of human dimethylarginine dimethylaminohydrolase-2 improved endothelial dysfunction in diabetic rat aortas and high glucose-treated endothelial cells.
    Lu CW, Guo Z, Feng M, Wu ZZ, He ZM, Xiong Y.
    Atherosclerosis; 2010 Mar 23; 209(1):66-73. PubMed ID: 19775692
    [Abstract] [Full Text] [Related]

  • 11. Genetic variation in the dimethylarginine dimethylaminohydrolase 1 gene (DDAH1) is related to asymmetric dimethylarginine (ADMA) levels, but not to endothelium-dependent vasodilation.
    Lind L, Ingelsson E, Kumar J, Syvänen AC, Axelsson T, Teerlink T.
    Vasc Med; 2013 Aug 23; 18(4):192-9. PubMed ID: 23892448
    [Abstract] [Full Text] [Related]

  • 12. Accelerated onset of senescence of endothelial progenitor cells in patients with type 2 diabetes mellitus: role of dimethylarginine dimethylaminohydrolase 2 and asymmetric dimethylarginine.
    Yuan Q, Hu CP, Gong ZC, Bai YP, Liu SY, Li YJ, Jiang JL.
    Biochem Biophys Res Commun; 2015 Mar 20; 458(4):869-76. PubMed ID: 25701782
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Apolipoprotein E polymorphism modulation of asymmetric dimethylarginine in hypertensive patients is determined by renal function.
    Marrocos MS, Teixeira AA, Quinto BM, Carmona Sde M, Kuniyoshi M, Rodrigues CJ, Dalboni MA, Manfredi S, Canziani ME, Batista MC.
    Lipids Health Dis; 2016 Jan 20; 15():14. PubMed ID: 26790728
    [Abstract] [Full Text] [Related]

  • 15. Hypoxia causes increased monocyte nitric oxide synthesis which is mediated by changes in dimethylarginine dimethylaminohydrolase 2 expression in animal and human models of normobaric hypoxia.
    Lambden S, Martin D, Vanezis K, Lee B, Tomlinson J, Piper S, Boruc O, Mythen M, Leiper J.
    Nitric Oxide; 2016 Aug 31; 58():59-66. PubMed ID: 27319282
    [Abstract] [Full Text] [Related]

  • 16. Nebivolol reduces asymmetric dimethylarginine in endothelial cells by increasing dimethylarginine dimethylaminohydrolase 2 (DDAH2) expression and activity.
    Garbin U, Pasini AF, Stranieri C, Manfro S, Boccioletti V, Cominacini L.
    Pharmacol Res; 2007 Dec 31; 56(6):515-21. PubMed ID: 17977009
    [Abstract] [Full Text] [Related]

  • 17. Reduced Renal Methylarginine Metabolism Protects against Progressive Kidney Damage.
    Tomlinson JA, Caplin B, Boruc O, Bruce-Cobbold C, Cutillas P, Dormann D, Faull P, Grossman RC, Khadayate S, Mas VR, Nitsch DD, Wang Z, Norman JT, Wilcox CS, Wheeler DC, Leiper J.
    J Am Soc Nephrol; 2015 Dec 31; 26(12):3045-59. PubMed ID: 25855779
    [Abstract] [Full Text] [Related]

  • 18. Reduced renal plasma clearance does not explain increased plasma asymmetric dimethylarginine in hypertensive subjects with mild to moderate renal insufficiency.
    Ronden RA, Houben AJ, Teerlink T, Bakker JA, Bierau J, Stehouwer CD, De Leeuw PW, Kroon AA.
    Am J Physiol Renal Physiol; 2012 Jul 01; 303(1):F149-56. PubMed ID: 22552932
    [Abstract] [Full Text] [Related]

  • 19. Association of the -449GC and -1151AC polymorphisms in the DDAH2 gene with asymmetric dimethylarginine and erythropoietin resistance in Chinese patients on maintenance hemodialysis.
    Wang T, Zhang Y, Niu K, Wang L, Shi Y, Liu B.
    Clin Exp Pharmacol Physiol; 2017 Sep 01; 44(9):961-964. PubMed ID: 28590543
    [Abstract] [Full Text] [Related]

  • 20. Dimethylarginine dimethylaminohydrolase prevents progression of renal dysfunction by inhibiting loss of peritubular capillaries and tubulointerstitial fibrosis in a rat model of chronic kidney disease.
    Matsumoto Y, Ueda S, Yamagishi S, Matsuguma K, Shibata R, Fukami K, Matsuoka H, Imaizumi T, Okuda S.
    J Am Soc Nephrol; 2007 May 01; 18(5):1525-33. PubMed ID: 17409314
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.